Balaxi Pharmaceuticals Company Profile: Products, Promoters and Clients

Balaxi Pharmaceuticals Ltd Company Description

Balaxi Pharmaceuticals Ltd is a company that focuses on producing, storing, selling, and supplying both branded and generic medicines. They operate based on Intellectual Property Rights (IPR).

Finding multibagger stocks is important for building wealth. Discover potential multibaggers at Sovrenn Discovery

Q1.What are the Products and Services offerings of Balaxi Pharmaceuticals Ltd?

Product Portfolio Balaxi Pharmaceuticals boasts a diverse portfolio with 610 registered pharmaceutical products. Their range includes Tablets (46%), Injectables (17%), Liquids (12%), Capsules (13%), and various other forms (12%). These products are sourced from manufacturers in India, China, and Portugal, all of which are certified by the World Health Organization's Good Manufacturing Practices (WHO-GMP).

Q2.Who are the Promoters of Balaxi Pharmaceuticals Ltd?

Ashish Maheshwari: Chairman & Managing Director

First generation entrepreneur and a qualified Chartered Accountant.Commenced business by supplying white labelled pharmaceutical formulations to various importer.Established Balaxi Group into a conglomerate that spans 4 continents.A person who recognises and appreciates knowledge,discipline, transparency & accountability

Minoshi Maheshwari: Non-Executive Director

A commerce graduate with 20 years of rich experience in the organization.Instrumental in creating Balaxi Group.A tenacious and persistent approach.A thought leader for the Group.Also heads CSR activities for the group.

Investing has built huge wealth for several HNI investors. Learn investing FREE OF CHARGE at Sovrenn Education  

Q3.Who are the Clients of Balaxi Pharmaceuticals Ltd?

Geographical Presence Balaxi Pharmaceuticals generates all its revenue from international sales. Their primary markets are Angola (59% of revenue), the Dominican Republic (28%), and Guatemala (13%). The company is also working on expanding into new markets, including Honduras, El Salvador, Nicaragua, the Central African Republic, and Mozambique, while continuing to grow in its current markets.

Distribution Networks Balaxi Pharmaceuticals has established a robust distribution network, consisting of 37 warehouses and a fleet of company-owned vehicles spread across four countries. In FY22, the company introduced 476 new Stock Keeping Units (SKUs) to its inventory.

Also Read: Bafna Pharmaceuticals Ltd. Company Profile:Products,Promoters and Clients